10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $726,309 | -25.0% | 17,608 | +1.5% | 0.00% | -33.3% |
| Q2 2023 | $968,910 | +101462.9% | 17,351 | +1.2% | 0.00% | 0.0% |
| Q1 2023 | $954 | +43.2% | 17,139 | -6.2% | 0.00% | +50.0% |
| Q4 2022 | $666 | -99.8% | 18,264 | +28.2% | 0.00% | 0.0% |
| Q3 2022 | $406,000 | -31.1% | 14,245 | +9.5% | 0.00% | 0.0% |
| Q2 2022 | $589,000 | -66.4% | 13,006 | +10.6% | 0.00% | -71.4% |
| Q4 2021 | $1,751,000 | -15.5% | 11,758 | -17.4% | 0.01% | -36.4% |
| Q3 2021 | $2,073,000 | -30.2% | 14,243 | -6.1% | 0.01% | -38.9% |
| Q2 2021 | $2,970,000 | – | 15,167 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |